Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Matti Manner Insider Profile
4 Followers
Matti Manner, Director at Faron Pharmaceuticals Oy, holds 551.03K shares in Faron Pharmaceuticals Oy (Ticker: GB:FARN). Most recently, Matti Manner Bought 42,735p shares of Faron Pharmaceuticals Oy on Mar 28, 2019 for an estimated value of 30.00K.
Profitable Transactions
3 out of 3 Profitable Transactions
Average Return
+325.00%
Average return per transaction
Time Frame
Compare to
Insider Roles
Director
Roles that Matti Manner holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:Mar 28, 2019 - Mar 28, 2020
Return:+646.00%
The most profitable trade made by Matti Manner
Matti Manner's Trading History
List of latest transactions for each holding click on a transaction to see Matti Manner's performance on stock
You May Also Like
Matti Manner insider profile FAQ
What is the percentage of profitable transactions made by Matti Manner?
The percentage of profitable transactions made by Matti Manner is 100%.
What is the average return per transaction made by Matti Manner?
The average return per transaction made by Matti Manner is 325.00%.
What stocks does Matti Manner hold?
Matti Manner holds: GB:FARN stocks.
What was Matti Manner’s latest transaction?
Matti Manner latest transaction was an Informative Buy of 30.00K.
What was Matti Manner's most profitable transaction?
Matti Manner’s most profitable transaction was an Informative Buy of GB:FARN stock on March 28, 2019. The return on the trade was 646.00%.
What is Matti Manner's role in Faron Pharmaceuticals Oy?
Matti Manner's role in Faron Pharmaceuticals Oy is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.